Search

Search Constraints

You searched for: Author/Creator Glod, John

Search Results

1. 297 Modeling the efficacy of NY-ESO-1 TCR T cells (letetresgene autoleucel; GSK3377794) in patients with synovial sarcoma: correlations of response with transduced cell kinetics and biomarkers. (10th December 2020)

2. 297 Modeling the efficacy of NY-ESO-1 TCR T cells (letetresgene autoleucel; GSK3377794) in patients with synovial sarcoma: correlations of response with transduced cell kinetics and biomarkers. (9th November 2020)

3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

4. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

5. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

6. Case report of adrenocortical carcinoma associated with double germline mutations in MSH2 and RET. Issue 4 (21st February 2021)

7. Cediranib phase‐II study in children with metastatic alveolar soft‐part sarcoma (ASPS). Issue 12 (10th September 2019)

8. Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers. (26th August 2016)

9. Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory Cancers. (26th August 2016)